Literature DB >> 17210867

Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease.

Gerond Lake-Bakaar, Lynn Dustin, Jane McKeating, Kimberley Newton, Victoria Freeman, Simon D W Frost.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17210867     DOI： 10.1182/blood-2006-08-041525

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  18 in total

1.  CD4+ T-Cell-Dependent Reduction in Hepatitis C Virus-Specific Neutralizing Antibody Responses After Coinfection With Human Immunodeficiency Virus.

Authors:  Justin R Bailey; Kimberly A Dowd; Anna E Snider; William O Osburn; Shruti H Mehta; Gregory D Kirk; David L Thomas; Stuart C Ray
Journal:  J Infect Dis       Date:  2015-03-09       Impact factor: 5.226

2.  Broadly neutralizing antibodies abrogate established hepatitis C virus infection.

Authors:  Ype P de Jong; Marcus Dorner; Michiel C Mommersteeg; Jing W Xiao; Alejandro B Balazs; Justin B Robbins; Benjamin Y Winer; Sherif Gerges; Kevin Vega; Rachael N Labitt; Bridget M Donovan; Erick Giang; Anuradha Krishnan; Luis Chiriboga; Michael R Charlton; Dennis R Burton; David Baltimore; Mansun Law; Charles M Rice; Alexander Ploss
Journal:  Sci Transl Med       Date:  2014-09-17       Impact factor: 17.956

3.  Hepatitis C Virus-related Mixed Cryoglobulinemia: Pathogenesis, Clinica Manifestations, and New Therapies.

Authors:  Neal J Schamberg; Gerond V Lake-Bakaar
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-09

Review 4.  Hepatitis C virus-induced cryoglobulinemia.

Authors:  Edgar D Charles; Lynn B Dustin
Journal:  Kidney Int       Date:  2009-07-15       Impact factor: 10.612

Review 5.  Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment.

Authors:  Carlo Visco; Silvia Finotto
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

6.  CD4+ T-cell recovery with suppressive ART-induced rapid sequence evolution in hepatitis C virus envelope but not NS3.

Authors:  Lin Liu; David Nardo; Eric Li; Gary P Wang
Journal:  AIDS       Date:  2016-03-13       Impact factor: 4.177

Review 7.  Hepatitis C virus reactivation in cancer patients in the era of targeted therapies.

Authors:  Ozan Yazici; Mehmet Ali Nahit Sendur; Sercan Aksoy
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

8.  'Les liaisons dangereuses': Hepatitis C, Rituximab and B-cell non-Hodgkin's lymphomas.

Authors:  Massimo Marignani; Michela di Fonzo; Paola Begini; Elia Gigante; Ilaria Deli; Adriano M Pellicelli; Sara Gallina; Emanuela de Santis; Gianfranco Delle Fave; M Christina Cox
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-04-06

Review 9.  Advances in HCV and Cryoglobulinemic Vasculitis in the Era of DAAs: Are We at the End of the Road?

Authors:  Chalermrat Bunchorntavakul; Robert Mitrani; K Rajender Reddy
Journal:  J Clin Exp Hepatol       Date:  2017-12-07

10.  Changes in hepatitis C virus antibody titer and viral RNA load in non-Hodgkin's lymphoma patients after rituximab chemotherapy.

Authors:  Y Tsutsumi; K Ichiki; S Shiratori; T Kawamura; J Tanaka; M Asaka; M Imamura; N Masauzi
Journal:  Int J Lab Hematol       Date:  2008-02-14       Impact factor: 2.877
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.